loadpatents
name:-0.029118061065674
name:-0.015129089355469
name:-0.0010941028594971
LUCKING; Ulrich Patent Filings

LUCKING; Ulrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for LUCKING; Ulrich.The latest application filed is for "novel ptefb inhibiting macrocyclic compounds".

Company Profile
0.43.56
  • LUCKING; Ulrich - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Ptefb Inhibiting Macrocyclic Compounds
App 20220281892 - LUCKING; Ulrich ;   et al.
2022-09-08
Ptefb Inhibiting Macrocyclic Compounds
App 20220267353 - LUCKING; Ulrich ;   et al.
2022-08-25
PTEFb inhibiting macrocyclic compounds
Grant 11,254,690 - Lucking , et al. February 22, 2
2022-02-22
PTEFb inhibiting macrocyclic compounds
Grant 11,242,356 - Lucking , et al. February 8, 2
2022-02-08
2-(morpholin-4-yl)-1,7-naphthyridines
App 20200383991 - WORTMANN; Lars ;   et al.
2020-12-10
Novel Ptefb Inhibiting Macrocyclic Compounds
App 20200347079 - LUCKING; Ulrich ;   et al.
2020-11-05
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 10,772,893 - Wortmann , et al. Sept
2020-09-15
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
Grant 10,729,680 - Lucking , et al.
2020-08-04
Macrocyclic sulfondiimine compounds
Grant 10,717,749 - Lucking , et al.
2020-07-21
Novel Ptefb Inhibiting Macrocyclic Compounds
App 20200123174 - Lucking; Ulrich ;   et al.
2020-04-23
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
App 20190142812 - LUCKING; Ulrich ;   et al.
2019-05-16
Modified macrocyclic compounds
Grant 10,214,542 - Lucking , et al. Feb
2019-02-26
Novel Modified Macrocyclic Compounds
App 20180282346 - LUCKING; Ulrich ;   et al.
2018-10-04
Novel Macrocyclic Sulfondiimine Compounds
App 20180273548 - LUCKING; Ulrich ;   et al.
2018-09-27
2-(morpholin-4-yl)-1,7-naphthyridines
App 20180256591 - WORTMANN; Lars ;   et al.
2018-09-13
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,993,484 - Wortmann , et al. June 12, 2
2018-06-12
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,962,389 - Lucking , et al. May 8, 2
2018-05-08
Macrocyclic compounds
Grant 9,963,464 - Lucking , et al. May 8, 2
2018-05-08
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
Grant 9,902,716 - Kosemund , et al. February 27, 2
2018-02-27
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
Grant 9,884,849 - Kosemund , et al. February 6, 2
2018-02-06
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,877,954 - Lucking , et al. January 30, 2
2018-01-30
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Grant 9,856,242 - Kosemund , et al. January 2, 2
2018-01-02
Compounds For The Treatment Of Cancer
App 20170342064 - SCHULZE; Volker ;   et al.
2017-11-30
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
Grant 9,790,189 - Lucking , et al. October 17, 2
2017-10-17
Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
Grant 9,770,445 - Kosemund , et al. September 26, 2
2017-09-26
Fluorinated Benzofuranyl-pyrimidine Derivatives Containing A Suflone Group
App 20170226092 - KOSEMUND; Dirk ;   et al.
2017-08-10
Fluorinated Benzofuranyl-pyrimidine Derivatives Containing A Sulfoximine Group
App 20170217938 - KOSEMUND; Dirk ;   et al.
2017-08-03
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20170217949 - LUCKING; Ulrich ;   et al.
2017-08-03
2-(morpholin-4-yl)-1,7-naphthyridines
App 20170216304 - WORTMANN; Lars ;   et al.
2017-08-03
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20170202815 - LUCKING; Ulrich ;   et al.
2017-07-20
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Grant 9,708,293 - Lucking , et al. July 18, 2
2017-07-18
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Grant 9,669,034 - Lucking , et al. June 6, 2
2017-06-06
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Grant 9,670,161 - Lucking , et al. June 6, 2
2017-06-06
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
Grant 9,650,361 - Lucking , et al. May 16, 2
2017-05-16
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Grant 9,650,340 - Lucking , et al. May 16, 2
2017-05-16
Prodrug derivatives of substituted triazolopyridines
Grant 9,586,958 - Schulze , et al. March 7, 2
2017-03-07
Novel Macrocyclic Compounds
App 20170029439 - LUCKING; Ulrich ;   et al.
2017-02-02
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,549,932 - Wortmann , et al. January 24, 2
2017-01-24
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfondiimine Group
App 20170015634 - LUCKING; Ulrich ;   et al.
2017-01-19
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfone Group
App 20170001989 - KOSEMUND; Dirk ;   et al.
2017-01-05
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Grant 9,499,492 - Lucking , et al. November 22, 2
2016-11-22
2-(morpholin-4-yl)-1,7-naphthyridines
App 20160287604 - Wortmann; Lars ;   et al.
2016-10-06
Prodrug Derivatives Of Substituted Triazolopyridines
App 20160207915 - Schulze; Volker ;   et al.
2016-07-21
Novel Compounds For The Treatment Of Cancer
App 20160207928 - SCHULZE; Volker ;   et al.
2016-07-21
Substituted Benzylpyrazoles
App 20160151370 - HITCHCOCK; Marion ;   et al.
2016-06-02
Sulfoximine Substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives And Their Use As Cdk9 Kinase Inhibitors
App 20160143893 - KOSEMUND; Dirk ;   et al.
2016-05-26
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfoximine Group
App 20150291528 - Lucking; Ulrich ;   et al.
2015-10-15
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfoximine Group
App 20150291537 - Lucking; Ulrich ;   et al.
2015-10-15
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfoximine Group
App 20150291559 - Lucking; Ulrich ;   et al.
2015-10-15
N-(pyridin-2-yl)pyrimidin-4-amine Derivatives Containing A Sulfone Group
App 20150274695 - Lucking; Ulrich ;   et al.
2015-10-01
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine Derivatives Containing A Sulfone Group
App 20150274666 - Lucking; Ulrich ;   et al.
2015-10-01
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl Amines Containing A Sulfone Group
App 20150259300 - Lucking; Ulrich ;   et al.
2015-09-17
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Grant 9,133,171 - Lucking , et al. September 15, 2
2015-09-15
Disubstituted 5-fluoro-pyrimidines
Grant 9,108,926 - Lucking , et al. August 18, 2
2015-08-18
Disubstituted 5-fluoro Pyrimidine Derivatives Containing A Sulfoximine Group
App 20150005329 - Lucking; Ulrich ;   et al.
2015-01-01
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Grant 8,916,557 - Lucking , et al. December 23, 2
2014-12-23
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group
App 20140315906 - Lucking; Ulrich ;   et al.
2014-10-23
Disubstituted 5-fluoro-pyrimidines
App 20140228387 - Lucking; Ulrich ;   et al.
2014-08-14
Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine
Grant 8,802,686 - Lucking , et al. August 12, 2
2014-08-12
Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
Grant 8,735,412 - Lucking , et al. May 27, 2
2014-05-27
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
App 20140045852 - Lucking; Ulrich ;   et al.
2014-02-13
Use Of Novel Pan-cdk Inhibitors For Treating Tumors
App 20130210846 - Lucking; Ulrich ;   et al.
2013-08-15
Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents
Grant 8,507,510 - Lucking , et al. August 13, 2
2013-08-13
Pharmaceutically Active Disubstituted Triazine Derivatives
App 20130079345 - Eickhoff; Jan ;   et al.
2013-03-28
Substituted (Heteroarylmethyl)thiohydantoins
App 20120251551 - Lucking; Ulrich ;   et al.
2012-10-04
(Heteroarylmethyl) Thiohydantoins as anticancer drugs
App 20120238533 - Cleve; Arwed ;   et al.
2012-09-20
Sulfoximine-substituted Anilinopyrimidine Derivatives As Cdk Inhibitors, The Production Thereof, And Use As Medicine
App 20110294838 - Lucking; Ulrich ;   et al.
2011-12-01
Sulfone-substituted Anilinopyrimidine Derivatives As Cdk Inhibitors, The Production Thereof, And Use As A Medicine
App 20110251222 - Lucking; Ulrich ;   et al.
2011-10-13
Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
Grant 8,003,787 - Eis , et al. August 23, 2
2011-08-23
Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
Grant 7,825,128 - Lucking , et al. November 2, 2
2010-11-02
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
Grant 7,750,000 - Prien , et al. July 6, 2
2010-07-06
Sulfoximine-substituted Pyrimidines As Cdk- And/or Vegf Inhibitors, Their Production And Use As Pharmaceutical Agents
App 20100076000 - Lucking; Ulrich ;   et al.
2010-03-25
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,598,260 - Brumby , et al. October 6, 2
2009-10-06
Novel Sulphoximine-substituted Quinoline And Quinazoline Derivatives As Kinase Inhibitors
App 20090226377 - EIS; Knut ;   et al.
2009-09-10
Substituted Sulfonamido-macrocycles As Tie2 Inhibitors And Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods Of Preparing Same And Uses Of Same
App 20090005373 - Hartung; Ingo ;   et al.
2009-01-01
CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20080039447 - Brumby; Thomas ;   et al.
2008-02-14
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,291,624 - Brumby , et al. November 6, 2
2007-11-06
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
Grant 7,288,547 - Lucking , et al. October 30, 2
2007-10-30
Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
App 20070232632 - Lucking; Ulrich ;   et al.
2007-10-04
Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases
App 20070191393 - Lucking; Ulrich ;   et al.
2007-08-16
Compound and a composition including such a compound
Grant 7,235,561 - Brumby , et al. June 26, 2
2007-06-26
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
App 20070093490 - Prien; Olaf ;   et al.
2007-04-26
Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
App 20060111378 - Cleve; Arwed ;   et al.
2006-05-25
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040224966 - Brumby, Thomas ;   et al.
2004-11-11
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040102630 - Brumby, Thomas ;   et al.
2004-05-27
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
App 20040063737 - Lucking, Ulrich ;   et al.
2004-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed